Clinical expression of nickel contact dermatitis primed by diagnostic patch test by Theler, B et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2009
Clinical expression of nickel contact dermatitis primed by diagnostic patch
test
Theler, B; Bucher, C; French, L E; Ballmer Weber, B; Hofbauer, G F L
Abstract: INTRODUCTION: Persistence of allergen and immunocompetent cells at sites of healed con-
tact dermatitis has been reported. Flare-up reactions triggered by patch testing and after systemic
provocation with allergen are well-known phenomena. To our knowledge, we report the first flare-up of a
previous patch test site following casual cutaneous application of nickel in an individual with hitherto la-
tent nickel sensitization. CASE REPORT: Patch testing in a 23-year-old female patient was performed for
dermatitis following application of various gels and adhesive bandages: positive delayed-type hypersensi-
tivity reactions were noted for nickel sulfate and potassium dichromate. The patient had never noticed
skin reactions to nickel-containing items before. Three weeks following these patch tests, the patient
wore earrings which in the past had been well tolerated. She subsequently developed dermatitis of both
earlobes within hours and dermatitis at the site of nickel patch testing within a day. CONCLUSIONS:
Nickel exposure for 48 h in a patch test is sufficient to induce overt delayed-type hypersensitivity on re-
exposure with a previously tolerated antigen in a previously clinically unresponsive individual. Antigen
and/or antigen-specific effector cells at the site of previous positive patch testing can be recruited into a
delayed-type hypersensitivity reaction for a prolonged period of time.
DOI: 10.1159/000212119
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-29825
Published Version
Originally published at:
Theler, B; Bucher, C; French, L E; Ballmer Weber, B; Hofbauer, G F L (2009). Clinical expres-
sion of nickel contact dermatitis primed by diagnostic patch test. Dermatology, 219(1):73-76. DOI:
10.1159/000212119
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Case Report 
 Dermatology 2009;219:73–76 
 DOI: 10.1159/000212119 
 Clinical Expression of Nickel Contact Dermatitis 
Primed by Diagnostic Patch Test 
 Barbara Theler    Christoph Bucher    Lars E. French    Barbara Ballmer Weber    
Günther F.L. Hofbauer  
 Allergy Unit, Dermatology Department, University Hospital,  Zurich , Switzerland
 
patch testing can be recruited into a de-
layed-type hypersensitivity reaction for a 
prolonged period of time. 
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 Introduction 
 Delayed-type hypersensitivity is medi-
ated by the immune system. Following ini-
tial allergen contact, sensitization develops 
and may lead to allergic contact dermatitis 
upon repeated allergen exposure. Clinical-
ly, erythema, swelling, blistering, itching 
and weeping at the site of contact develop, 
and spreading to uninvolved sites may oc-
cur during prolonged exposure to the elic-
iting antigen. Nickel is the most common 
allergen eliciting delayed-type hypersensi-
tivity contact dermatitis. Nickel allergy af-
fects people of all ages with female predom-
inance most likely due to increased nickel 
contact in women via nickel-containing 
items. Jewelry is assumed to account for the 
observed female predilection.
 In delayed-type hypersensitivity, pro-
longed allergen persistence as well as per-
sistence of immunocompetent cells at skin 
sites of healed contact dermatitis have 
been demonstrated  [1] . Postoccupational 
dermatitis in work-related allergic contact 
dermatitis is thought to be caused by aller-
gen persistence (e.g. allergic dermatitis to 
chromate in masons)  [2] as well as by epi-
tope spreading to autoantigens. These fac-
tors are postulated to continue driving in-
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 Abstract 
 Introduction: Persistence of allergen and 
immunocompetent cells at sites of healed 
contact dermatitis has been reported. Flare-
up reactions triggered by patch testing and 
after systemic provocation with allergen are 
well-known phenomena. To our knowledge, 
we report the first flare-up of a previous 
patch test site following casual cutaneous 
application of nickel in an individual with 
hitherto latent nickel sensitization.  Case Re-
port: Patch testing in a 23-year-old female 
patient was performed for dermatitis follow-
ing application of various gels and adhesive 
bandages: positive delayed-type hypersen-
sitivity reactions were noted for nickel sul-
fate and potassium dichromate. The patient 
had never noticed skin reactions to nickel-
containing items before. Three weeks fol-
lowing these patch tests, the patient wore 
earrings which in the past had been well tol-
erated. She subsequently developed derma-
titis of both earlobes within hours and der-
matitis at the site of nickel patch testing 
within a day.  Conclusions: Nickel exposure 
for 48 h in a patch test is sufficient to induce 
overt delayed-type hypersensitivity on re-
exposure with a previously tolerated anti-
gen in a previously clinically unresponsive 
individual. Antigen and/or antigen-specific 
effector cells at the site of previous positive 
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flammation of the skin in spite of strict 
avoidance of the causative allergen.
 Patch testing is used to identify aller-
gens responsible for delayed-type hyper-
sensitivity. Standard and suspected aller-
gens are applied for 48 h under occlusion 
using Finn chambers on an uninvolved 
skin site such as the back. In delayed-type 
hypersensitivity, dermatitis in the patch 
test area develops and progresses even af-
ter removal of the applied allergen, distin-
guishing such a reaction from the more 
common purely irritant skin reactions. A 
Swedish study analyzing allergy patch 
tests using electron microscopy showed 
maintained activity of inflammatory cells 
in the epidermis and dermis 15–75 days 
following patch testing  [3] . Flare-up of 
 delayed-type hypersensitivity dermatitis 
triggered by patch testing  [4–6] and un-
specific widespread inflammatory reac-
tions within the patch test area (angry 
back) are well-known phenomena  [7–10] .
 Case Report 
 A 23-year-old female patient was re-
ferred to our allergy unit for a general 
checkup. She reported immediate-type al-
lergies such as seasonal rhinoconjunctivitis 
and allergic asthma with pollen-associated 
food allergies and a history of drug rash to 
penicillin. She had been in rheumatological 
care for systemic lupus erythematosus for
9 years without skin involvement.
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 On initial examination, the patient 
complained about dermatitis following 
application of various gels and adhesive 
bandages. Patch testing was performed. A 
standard panel of allergens was applied. 
Further allergens tested comprised dis-
infectants, preservatives, cosmetics, un-
guents, creams, leather and medical drugs. 
A complete list of allergens tested is shown 
in  table 1 . The vehicle used for test sub-
stances (by Almirall Hermal GmbH, Rein-
bek, Germany) was either vaseline or wa-
ter, depending on solubility, with a dilu-
tion ranging from 0.01 to 100%. Finn 
chambers on Scanpor (Almirall Hermal 
GmbH) served as chambers. Adhesive 
bandages were attached directly to the 
skin. With application on day 0, the out-
come readings took place on day 2 and
day 3.
 Positive delayed-type hypersensitivity 
reactions were noted for nickel sulfate and 
potassium dichromate. Different types of 
adhesive bandages induced an irritant re-
action. All other allergens tested negative 
( table 1 ). The patient had never noticed 
skin reactions to nickel-containing items 
such as jewelry, belt buckles, the inside 
part of pant buttons with nickel coating, 
brassieres or other such materials. The pa-
tient was thus considered to have a latent 
delayed-type nickel sensitization without 
clinical relevance.
 Three weeks following the above-men-
tioned patch test, the patient wore earrings 
which in the past had been well tolerated. 
She subsequently developed dermatitis of 
both earlobes within hours, and dermati-
tis at the site of nickel patch testing within 
a day.  Figure 1 shows a large part of the 
patient’s back displaying the previous 
patch site. No other patch test fields react-
ed; in particular, the test field for potassi-
um dichromate, the second allergen that 
had tested positive on the patch test in ad-
dition to nickel, remained unchanged.  Fig-
ure 2 shows dermatitis of the earlobe ob-
served after a short period of wearing jew-
elry. Although a dimethylglyoxime test, a 
procedure to detect nickel release, was not 
performed, we assume liberation of nickel 
by the earrings worn.
 Discussion 
 Allergic contact dermatitis is a delayed-
type hypersensitivity reaction involving a 
cell-mediated allergic response with two 
essential stages: an induction or sensitiza-
tion phase, which sensitizes the immune 
system to an allergen, and an elicitation 
phase, in which an inflammatory allergic 
reaction is triggered. During this process, 
allergen-specific skin-homing lympho-
cytes invade the respective skin area and 
result, after cessation of the acute reaction, 
in the generation of long-lived memory 
cells which accelerate and aggravate later 
episodes of contact dermatitis. Continu-
ing manifestation of delayed-type hyper-
sensitivity dermatitis in spite of allergen 
avoidance is well known, especially in oc-
cupational dermatitis  [2, 11, 12] . Defects in 
downregulation of the contact hypersen-
sitivity reaction or repeated antigen stim-
ulation are assumed to cause flare-ups
or persistence of allergic contact dermati-
tis  [1] .
 Flare-up reactions at previous patch 
test or contact allergy sites after peroral 
provocation with the specific antigen 
(mostly nickel, betalactams and gold) are 
well-known phenomena discussed in sev-
eral studies and case reports  [13–18] . How-
ever, a flare-up at previous patch test sites 
following cutaneous exposure has only 
been described in mice  [19] : nickel-sensi-
tized mice showed a flare-up reaction at 
one ear when the other ear had been ex-
posed to the antigen.
 To our knowledge, we report the first 
flare-up of a previous patch test site follow-
ing cutaneous application of nickel in an 
individual with hitherto clinically latent 
nickel sensitization. The conclusion from 
this clinical observation is that nickel ex-
posure for 48 h in a patch test area under 
occlusion is sufficient to induce overt de-
layed-type hypersensitivity on re-exposure 
with a previously tolerated antigen in a pre-
viously clinically unresponsive individual. 
Similar observations have been made in an 
English study with fragrance mix I  [20] . In 
our case, we interpret the positive patch 
 Fig. 1. Flare-up of previous positive nickel patch test field. 
C
o
lo
r v
er
si
o
n 
av
ai
la
b
le
 o
n
lin
e
C
o
lo
r v
er
si
o
n 
av
ai
la
b
le
 o
n
lin
e
 Fig. 2. Dermatitis of the earlobe after wearing nickel-con-
taining earrings. 
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test to nickel not as a result of active sensi-
tization, a rare event but reported for para-
phenylene diamine  [21, 22] , because previ-
ous exposure to nickel before patch testing 
has to be assumed due to the ubiquity of 
nickel. Rather, we assume that patch test-
ing boosted a previously acquired, clini-
cally silent sensitization to nickel in this 
individual, resulting in overt delayed-type 
hypersensitivity on nickel re-exposure.
 Nickel contact dermatitis on the ear 
was followed by a distant flare-up of the 
nickel patch test site. We interpret this as 
an antigen-specific reaction: neither did 
any other patch test site flare up (analo-
gous to an angry back reaction) nor did po-
tassium dichromate in particular, the sec-
ond allergen which had shown a positive 
patch test reaction, cause a flare-up. We 
speculate that nickel allergen may remain 
locally at the site of previous patch testing, 
possibly by means of antigen-presenting 
cells, for weeks. Antigen-specific T lym-
phocytes with particular homing features 
may have been involved, a pathway that is 
discussed in the case of fixed drug erup-
tion  [23, 24] . 
 In summary, we report the first case of 
a previously positive patch test site flaring 
up following distant contact dermatitis in 
a previously unresponsive person. Local 
persistence of antigen, professional anti-
gen-presenting cells or lymphocytes with 
restricted homing behavior may explain 
our observation. 
Table 1. List of allergens tested and test results
Substance Dilu-
tion, %
48 h 72 h
Lanolin alcohol 30 – –
p-Phenylene diamine 1 – –
Thiuram mix 1 – –
Neomycin sulfate 20 – –
Cobalt (II) chloride 1 irritated irritated
Nickel (II) sulfate 5 + +
Benzocaine 5 – –
Colophonium 20 – –
N-isopropyl-N-phenyl-p-
phenylene diamine 0.1 – –
Potassium dichromate 0.5 + +
Mercapto mix 2 – –
Epoxy resin 1 – –
Balsam of Peru 25 – –
p-tert-Butylphenol formaldehyde
resin 1 – –
Paraben mix 16 – –
Fragrance mix 8 – –
Mercaptobenzothiazole 2 – –
Mercury (II) amide chloride 1 – –
Cetyl stearyl alcohol 20 – –
Zinc diethyldithiocarbamate 1 – –
White vaseline 100 – –
Formaldehyde 1 – –
Chloromethylisothiazolinone 0.01 – –
Benzalkonium chloride 0.1 – –
Bronopol 0.5 – –
Tixocortol pivalate 1 – –
Hydrocortisone-17-butyrate 0.1 – –
Propolis 10 – –
Bufexamab 5 – –
Lyral 5 – –
Sorbic acid 2 – –
Chloracetamide 0.2 – –
Cetylpyridinium chloride 0.1 – –
Cetalkonium chloride 0.1 – –
Diazolidinyl urea 2 – –
Substance Dilu-
tion, %
48 h 72 h
Chlorocresol 1 – –
Dichlorophene 0.5 – –
Phenyl mercury acetate 0.05 – –
Chloroxylenol 1 – –
Glyoxal trimer 1 – –
Iodine 0.5 – –
Thiomersal 0.1 – –
Imidazolidinyl urea 2 – –
Dibromodicyanobutane/
phenoxyethanol 1 – –
1-(3-Chloroallyl)-3,5,7-triaza-1-
azonia-adamantane chloride 1 – –
Triclosan 2 – –
Glutaraldehyde 0.3 – –
Chlorhexidine gluconate 0.5 – –
Butylhydroxytoluol 2 – –
Butylhydroxyanisole 2 – –
Dodecyl gallate 0.3 – –
tert-Butyl hydrochinone 1 – –
Hexachlorophene 1 – –
Benzoic acid 5 – –
Polyethylene glycol ointment DAB8 100 – –
Isopropyl myristate 10 – –
Adeps lanae 30 – –
Propylene glycol 5 – –
Trolamine (triethanolamine) 2.5 – –
Amerchol L 101 50 – –
Sorbitan sesquioleate 20 – –
Lanolin alcohol ointment DAB9 100 – –
Dermaplast elastic (bandage material) – –
Sparablanc (bandage material) irritated irritated
Isofix fleece (bandage material) – –
Transpore (bandage material) irritated irritated
Sparablanc plastic (bandage material) – –
Micropore (bandage material) – –
Fixomull fleece (bandage material) – –
Mefix (bandage material) – –
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